User profiles for Clara Hwang
 | Clara HwangHenry Ford Health System Verified email at hfhs.org Cited by 4114 |
Co‐ordinate regulation of Salmonella typhimurium invasion genes by environmental and regulatory factors is mediated by control of hilA expression
V Bajaj, RL Lucas, C Hwang, CA Lee - Molecular microbiology, 1996 - Wiley Online Library
During infection of their hosts, salmonellae enter intestinal epithelial cells. It has been
proposed that when Salmonellatyphimurium is present in the intestinal lumen, several …
proposed that when Salmonellatyphimurium is present in the intestinal lumen, several …
Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial
…, P Maton, JR Breiter, C Hwang… - Official journal of the …, 2001 - journals.lww.com
OBJECTIVE: In patients with gastroesophageal reflux disease (GERD), esomeprazole, the S-isomer
of omeprazole, has demonstrated pharmacological and clinical benefits beyond …
of omeprazole, has demonstrated pharmacological and clinical benefits beyond …
[HTML][HTML] Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer …
Background Patients with cancer may be at high risk of adverse outcomes from severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of …
hilA is a novel ompR/toxR family member that activates the expression of Salmonella typhimurium invasion genes
V Bajaj, C Hwang, CA Lee - Molecular microbiology, 1995 - Wiley Online Library
During infection of its hosts, Salmonella enters intestinal epithelial cells. Many Salmonella
typhimurium genes required for bacterial entry into host cells are encoded on a 40 kb ‘…
typhimurium genes required for bacterial entry into host cells are encoded on a 40 kb ‘…
Treatment of chronic posterior laryngitis with esomeprazole
…, RA Iannuzzi, JA Crawley, C Hwang… - The …, 2006 - Wiley Online Library
Objective: To evaluate the efficacy of acid‐suppressive therapy with the proton pump inhibitor
esomeprazole on the signs and symptoms of chronic posterior laryngitis (CPL) in patients …
esomeprazole on the signs and symptoms of chronic posterior laryngitis (CPL) in patients …
[HTML][HTML] Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a …
…, U de Giorgi, EA Fomin, Y Zakharia, C Hwang… - The lancet …, 2022 - thelancet.com
Background The first interim analysis of the KEYNOTE-564 study showed improved disease-free
survival with adjuvant pembrolizumab compared with placebo after surgery in patients …
survival with adjuvant pembrolizumab compared with placebo after surgery in patients …
Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19
Importance COVID-19 is a life-threatening illness for many patients. Prior studies have
established hematologic cancers as a risk factor associated with particularly poor outcomes from …
established hematologic cancers as a risk factor associated with particularly poor outcomes from …
[HTML][HTML] Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM
…, L Heilbrun, Y Li, S Ali, S Sethi, O Hassan, C Hwang… - PloS one, 2012 - journals.plos.org
The emergence of castrate-resistant prostate cancer (CRPC) contributes to the high mortality
of patients diagnosed with prostate cancer (PCa), which in part could be attributed to the …
of patients diagnosed with prostate cancer (PCa), which in part could be attributed to the …
Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer
Objectives. Prostate cancer recurrence, evidenced by rising prostate-specific antigen (PSA)
levels after radical prostatectomy, is an increasingly prevalent clinical problem in need of …
levels after radical prostatectomy, is an increasingly prevalent clinical problem in need of …
Overcoming docetaxel resistance in prostate cancer: a perspective review
C Hwang - Therapeutic advances in medical oncology, 2012 - journals.sagepub.com
The treatment of metastatic castrate-resistant prostate cancer has been historically challenging,
with few therapeutic successes. Docetaxel was the first cytotoxic therapy associated with …
with few therapeutic successes. Docetaxel was the first cytotoxic therapy associated with …